logo
The National Academy of Sciences Elects 120 New Members For 2025

The National Academy of Sciences Elects 120 New Members For 2025

Forbes08-05-2025
The National Academy of Sciences has announced the 120 new members and 30 international members ... More elected in 2025.
The National Academy of Sciences has announced the 2025 election of 120 new members and 30 international members.
Election to the academy is for scientists who have been judged by their peers to have made distinguished and continuing achievements in original research. Membership in the Academy is widely regarded as one of the highest honors that can be bestowed on a scientist.
With the new members elected this year, the total number of active members now stands at 2,662, and the number of international members is 556. The international members, who are scholars with citizenship outside the United States, are considered nonvoting members of the Academy.
Nominations to be a member of the NAS can be made only by the existing members; there is no membership application process. Following a candidate's nomination, an extensive vetting process is conducted, resulting in a final ballot at the Academy's annual meeting in April each year. Currently, a maximum of 120 members can be elected annually; the maximum number of international members who can be elected is set at 30 each year.
Members are affiliated with scientific discipline in one of six categories:
The full list of the new members can be found here. This year, the new members were elected from a broad array of more than 50 colleges, universities, national laboratories and other research institutions.
Harvard University led the way with nine new members. It was followed closely by the University of California,Berkeley with eight and Stanford University with seven, Yale University and the Massachusetts Institute of Technology each had five faculty elected this year, while the California Institute of Technology and the University of Pennsylvania had four new members each.
Several other institutions, including the University of Chicago; the University of Virginia; UCLA; Michigan State University, the University of California, San Francisco; and the University of California, San Diego; had three members each elected to the Academy.
The National Academy of Sciences is a private, nonprofit institution that was established under a congressional charter signed by President Abraham Lincoln in 1863. Its mission is to recognize outstanding scientific achievements, foster a broad understanding of science and provide independent, authoritative, scientific advice to the government.
The National Research Council was formed by a presidential executive order from Woodrow Wilson in 1916 to expand the expertise available to the NAS in fulfilling the mission of its original Congressional charter.
Under the authority of that charter, the National Academy of Sciences established the National Academy of Engineering in 1964 and the Institute of Medicine in 1970 (which in 2015 became the National Academy of Medicine).
Today, the three Academies work together as the National Academies of Sciences, Engineering, and Medicine to 'provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions.' The Academies also encourage education and research and attempt to increase public understanding about science, engineering, and medicine.
The current president of the National Academy of Sciences is Marcia McNutt, who previously served as the 19th editor-in-chief of the Science journals (2013-2016) and director of the U.S. Geological Survey (2009-2013). McNutt is scheduled to give a State of the Science address on June 3 in Washington, D.C., where she will describe the current status of U.S. research and discuss how the scientific community can respond to a new and rapidly changing research environment.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Staying sharp, healthy hearts and beach-day calm: The week in Well+Being
Staying sharp, healthy hearts and beach-day calm: The week in Well+Being

Washington Post

time22 minutes ago

  • Washington Post

Staying sharp, healthy hearts and beach-day calm: The week in Well+Being

You're reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. This week we're thinking about healthy brains and hearts. The two are so closely linked, and we know what's good for one is often good for the other. We were excited to see some of the strongest evidence to date that you can protect your brain health with exercise, healthy eating, social interaction and brain games. A new study looked at people at risk of developing dementia because of a family history or other factors, and found a 'recipe' of lifestyle changes helped improve their cognitive function. About 45 percent of all dementia cases might be preventable, according to other research, so this is incredible news for anyone (everyone?) who's worried about their memory or brain health as they age. And back to that heart-mind connection. Those very same lifestyle changes that are so good for your brain often help your heart. Cardiologist Eric Topol shared 10 science-based ways to protect your ticker — plus there's an online tool you can use to find out how 'old' your heart is! — and I'm sure our minds would benefit, too. But before that … A mix of exercise, a healthy diet, social engagement and brain games could improve cognitive capabilities in older adults at risk of cognitive decline or dementia, a clinical trial has found. The study, known as U.S. POINTER, is the largest trial to examine how healthy lifestyle behaviors can improve brain health. Its results were published in JAMA and presented at the Alzheimer's Association International Conference on Monday in Toronto. 'If you can modify these and improve them, then it makes sense that you will improve your brain health and you might prevent dementia,' Kristine Yaffe, a professor and the vice chair of the department of psychiatry at the University of California at San Francisco, told our brain health writer, Richard Sima. Learn more about the study and how you can reduce your risk of dementia here. A free, newly developed online calculator reveals your heart's age and your risk of heart disease, according to a large-scale study of heart health published in JAMA Cardiology. Based on the most current equations about risks for cardiovascular disease, the calculator uses answers to a few simple questions about blood pressure, cholesterol status and other common measures of health, to determine your heart's biological age, which can be different from your body's chronological or calendar age. Fitness columnist Gretchen Reynolds writes that the calculator is at the vanguard of 'organ aging' tests, which use a variety of advanced techniques and algorithms to determine whether certain parts of our bodies are aging faster or slower than others. To find out more about organ aging and how to tell if your heart is as young as you are, read our story here. Our guest columnist is Eric Topol, MD, a cardiologist, professor and the executive vice president of Scripps Research in San Diego. He is the author of 'Super Agers: An Evidence-Based Approach to Longevity' and Ground Truths on Substack. While we've seen some major advances in treating heart disease, it remains the leading killer in the United States, even though about 80 percent of cases are considered preventable. Exercise is considered the single most effective medical intervention to protect against atherosclerosis and promote healthy aging. Physical activity lowers inflammation in the body. Evidence has shown that both aerobic and strength training forms of exercise are important. But only 1 in 4 Americans meet the two activity guidelines from the American Heart Association: aerobic exercise of 150 minutes per week of at least moderate physical activity, such as walking, bicycling on level ground, dancing or gardening, and strength training for at least two sessions per week, which typically translates to 60 minutes weekly. For more evidence-based steps Topol recommends you do to stave off heart disease, read the story here. And use our Ask a Doctor form to submit a question, and we may answer it in a future column. Here are a few things that brought us joy this week. Let's keep the conversation going. We want to hear from you! Email us at wellbeing@ Want to know more about 'joy' snacks? Reporter and former neuroscientist Richard Sima explains what they are and how they can make you feel happier. You can also read his advice as a comic.

New Jersey surgeon uses new drug that shines a light on lung cancer
New Jersey surgeon uses new drug that shines a light on lung cancer

CBS News

timean hour ago

  • CBS News

New Jersey surgeon uses new drug that shines a light on lung cancer

A new invention is shining a light on cancer and helping surgeons find microscopic lesions. The special light allows surgeons like New Jersey's Dr. Matthew Puc to find cancer they wouldn't normally be able to see. It's allowing them to treat small early-stage cancer and also potentially stop it from coming back. Amy Demurjiam is feeling hopeful about a brighter future thanks to a special kind of green illumination that's saving lives. And she's breathing a lot easier after surgery for early-stage lung cancer performed with assistance from an imaging agent called Cytalux. "It is a molecule that will specifically attach to lung cancer cells," said Puc, who is chief of thoracic surgery at Virtua Health. Cytalux is especially helpful for early-stage lung cancer, Puc said. With Cytaluz, the cancer is "clearly defined," he said. "If I can see the lesion, especially these smaller peripheral lesions, then I can do kind of a limited resection," Puc said. "I can take now, you know, 5 to 10% of someone's lung function instead of 25%." Healthy tissue is spared with Cytalux, which is administered intravenously before surgery. "This is, you know, first in class in terms of how this drug works," Puc said. And he said it's especially important for patients like Demurjiam, who was shocked to learn that what she thought was a cough from allergies was actually early-stage lung cancer. "It was brutal," Demurjiam said. "It was really, really scary." She had the surgery in March, and she feels lucky this new technology was available. "I'm thankful that they have it," she said. Cytalux is currently approved to treat lung and ovarian cancer, but it's also being tested for use with other kinds of cancer.

FDA Approves First Vagus Nerve Stimulation Device for RA
FDA Approves First Vagus Nerve Stimulation Device for RA

Medscape

timean hour ago

  • Medscape

FDA Approves First Vagus Nerve Stimulation Device for RA

The FDA has approved a medical device that stimulates the vagus nerve for the treatment of moderate-to-severe rheumatoid arthritis (RA) in patients who have not responded to — or cannot tolerate — biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs). The device, developed by SetPoint Medical in Valencia, California, is the first treatment of its kind approved for RA. The company is also planning trials for multiple sclerosis and Crohn's disease. Implanted into the neck, the Setpoint System is a multivitamin-sized device that stimulates the vagus nerve for 1 minute every day and 'is designed to activate innate anti-inflammatory pathways in the vagus nerve to reduce inflammation and restore immunologic setpoint,' according to a press release from SetPoint Medical on July 31. The device's approval was based on a randomized, double-blinded, and sham-controlled clinical study of 242 patients with RA. At 3 months, 35.2% of patients in the treatment group achieved 20% improvement in American College of Rheumatology response criteria (ACR20), compared with 24.2% in the sham group, according to trial results presented at the 2024 ACR annual meeting held in Washington, DC. ACR response rates and disease activity metrics improved over 12 months of follow-up, John Tesser, MD, a principal investigator of the trial, said in a statement. At 1 year, '75% of patients in the study were free of biologic or targeted synthetic DMARDs,' he said. Commercialization of the device will begin in certain US cities this year, with a larger expansion across the US planned in early 2026. SetPoint could not provide specifics on which cities are selected for this phased roll out due to confidentiality requirements.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store